Global Transdermal Skin Patches

Transdermal Skin Patches Comprehensive Study by Type (Drug in Adhesive, Matrix, Reservoir, Vapor, Other), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End Use (Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores) Players and Region - Global Market Outlook to 2025

Transdermal Skin Patches Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Transdermal Skin Patches Market?

A transdermal patch is defined as the medicated adhesive patch which is placed on the skin in order to deliver a specific dose of medication into the bloodstream. Various advantages associated with a transdermal patch such as reduce risk of trauma to the skin, controlled release of medication, avoid the first-pass metabolism, self-administration, and others. Increasing usage of transdermal Skin Patches in various application such as pain management, nicotine cessation is likely to be the prime driver for the growth of the market in future

The market study is being classified by Type (Drug in Adhesive, Matrix, Reservoir, Vapor and Other), by Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and major geographies with country level break-up.

Johnson & Johnson (United States), Novartis AG (Switzerland), Mylan N.V. (United States), Teva Pharmaceutical Industries (Israel), Luye Pharma Group (China), Hisamitsu Pharmaceutical (Japan), Mundipharma International (United Kingdom) and Purdue Pharma (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Purdue Pharma L.P. (United States), Endo International plc (Ireland) and Boehringer Ingelheim (Germany).

The Transdermal skin patch market is highly fragmented and dominated by a few global players and comprises several regional players. Some of the key manufacturers operating in the market are ProSolus, Inc., Tapemark, Medherant Limited, among others. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Transdermal Skin Patches market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Transdermal Skin Patches market by Type, Application and Region.

On the basis of geography, the market of Transdermal Skin Patches has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Prevalence of Chronic Diseases across the Worldwide
  • Technological Advancements in Transdermal Drug Delivery Systems in order to reduce cost and improve the quality of product

Market Trend
  • One of the latest Trends of this Market is the Rising Demand for Better Therapeutics at Affordable Costs of Transdermal Patch Products

Restraints
  • Issue related to Drug Failure and Recalls of Transdermal Patch Products
  • The problem regarding the possibility of skin irritation and limited to the certain drug only

Opportunities
  • Rising Collaborations between Pharmaceutical Companies and Drug Delivery Firms
  • Growing Demand from Emerging Economics market such as China and India

Challenges
  • Issue related to Technical Barriers Related to Skin Irritation as well as Permeability
  • Major Concern related to patients may use inappropriate of Products


Market Leaders and some development strategies
In August 2018, the Luye Pharma Group (China) company has signed an agreement with Bayer AG (Switzerland) company in order to acquire the global rights to the apleek contraceptive transdermal patch. Hence, this agreement enabled the company to strengthen its transdermal patch product portfolio
In March 2019, the Amneal Pharmaceuticals, Inc. (United States) Company has launched its generic version of Exelon patch which is available in 4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours. In addition, In January 2019, the company has also received Food and Drug Administration approval of its Rivastigmine Transdermal System. Hence, this launched will increase the product portfolio of the company.
According to the Food and Drug Administration, in order to confirm both qualities as well as the performance of generic transdermal delivery systems products and their robust therapeutic should be equal to their reference listed drugs. Hence, it may act restraint for the growth of the market in the future.

Key Target Audience
Transdermal Patch Manufacturers, Raw Material Suppliers, Distributors, Retailers, and Wholesalers, E-commerce industry and Traders, Importers, and Exporters

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Drug in Adhesive
  • Matrix
  • Reservoir
  • Vapor
  • Other
By Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By End Use
  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases across the Worldwide
      • 3.2.2. Technological Advancements in Transdermal Drug Delivery Systems in order to reduce cost and improve the quality of product
    • 3.3. Market Challenges
      • 3.3.1. Issue related to Technical Barriers Related to Skin Irritation as well as Permeability
      • 3.3.2. Major Concern related to patients may use inappropriate of Products
    • 3.4. Market Trends
      • 3.4.1. One of the latest Trends of this Market is the Rising Demand for Better Therapeutics at Affordable Costs of Transdermal Patch Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transdermal Skin Patches, by Type, Application, End Use and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Transdermal Skin Patches (Value)
      • 5.2.1. Global Transdermal Skin Patches by: Type (Value)
        • 5.2.1.1. Drug in Adhesive
        • 5.2.1.2. Matrix
        • 5.2.1.3. Reservoir
        • 5.2.1.4. Vapor
        • 5.2.1.5. Other
      • 5.2.2. Global Transdermal Skin Patches by: Application (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Pharmacies
      • 5.2.3. Global Transdermal Skin Patches by: End Use (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Online Pharmacies
        • 5.2.3.3. Independent Pharmacies & Drug Stores
      • 5.2.4. Global Transdermal Skin Patches Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Transdermal Skin Patches (Volume)
      • 5.3.1. Global Transdermal Skin Patches by: Type (Volume)
        • 5.3.1.1. Drug in Adhesive
        • 5.3.1.2. Matrix
        • 5.3.1.3. Reservoir
        • 5.3.1.4. Vapor
        • 5.3.1.5. Other
      • 5.3.2. Global Transdermal Skin Patches by: Application (Volume)
        • 5.3.2.1. Hospital Pharmacies
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Online Pharmacies
      • 5.3.3. Global Transdermal Skin Patches by: End Use (Volume)
        • 5.3.3.1. Hospital Pharmacies
        • 5.3.3.2. Online Pharmacies
        • 5.3.3.3. Independent Pharmacies & Drug Stores
      • 5.3.4. Global Transdermal Skin Patches Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Transdermal Skin Patches (Price)
      • 5.4.1. Global Transdermal Skin Patches by: Type (Price)
  • 6. Transdermal Skin Patches: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mylan N.V. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teva Pharmaceutical Industries (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Luye Pharma Group (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hisamitsu Pharmaceutical (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mundipharma International (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Purdue Pharma (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Transdermal Skin Patches Sale, by Type, Application, End Use and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Transdermal Skin Patches (Value)
      • 7.2.1. Global Transdermal Skin Patches by: Type (Value)
        • 7.2.1.1. Drug in Adhesive
        • 7.2.1.2. Matrix
        • 7.2.1.3. Reservoir
        • 7.2.1.4. Vapor
        • 7.2.1.5. Other
      • 7.2.2. Global Transdermal Skin Patches by: Application (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Pharmacies
      • 7.2.3. Global Transdermal Skin Patches by: End Use (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Online Pharmacies
        • 7.2.3.3. Independent Pharmacies & Drug Stores
      • 7.2.4. Global Transdermal Skin Patches Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Transdermal Skin Patches (Volume)
      • 7.3.1. Global Transdermal Skin Patches by: Type (Volume)
        • 7.3.1.1. Drug in Adhesive
        • 7.3.1.2. Matrix
        • 7.3.1.3. Reservoir
        • 7.3.1.4. Vapor
        • 7.3.1.5. Other
      • 7.3.2. Global Transdermal Skin Patches by: Application (Volume)
        • 7.3.2.1. Hospital Pharmacies
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Online Pharmacies
      • 7.3.3. Global Transdermal Skin Patches by: End Use (Volume)
        • 7.3.3.1. Hospital Pharmacies
        • 7.3.3.2. Online Pharmacies
        • 7.3.3.3. Independent Pharmacies & Drug Stores
      • 7.3.4. Global Transdermal Skin Patches Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Transdermal Skin Patches (Price)
      • 7.4.1. Global Transdermal Skin Patches by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transdermal Skin Patches: by Type(USD Million)
  • Table 2. Transdermal Skin Patches Drug in Adhesive , by Region USD Million (2014-2019)
  • Table 3. Transdermal Skin Patches Matrix , by Region USD Million (2014-2019)
  • Table 4. Transdermal Skin Patches Reservoir , by Region USD Million (2014-2019)
  • Table 5. Transdermal Skin Patches Vapor , by Region USD Million (2014-2019)
  • Table 6. Transdermal Skin Patches Other , by Region USD Million (2014-2019)
  • Table 7. Transdermal Skin Patches: by Application(USD Million)
  • Table 8. Transdermal Skin Patches Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 9. Transdermal Skin Patches Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 10. Transdermal Skin Patches Online Pharmacies , by Region USD Million (2014-2019)
  • Table 11. Transdermal Skin Patches: by End Use(USD Million)
  • Table 12. Transdermal Skin Patches Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 13. Transdermal Skin Patches Online Pharmacies , by Region USD Million (2014-2019)
  • Table 14. Transdermal Skin Patches Independent Pharmacies & Drug Stores , by Region USD Million (2014-2019)
  • Table 15. South America Transdermal Skin Patches, by Country USD Million (2014-2019)
  • Table 16. South America Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 17. South America Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 18. South America Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 19. Brazil Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 20. Brazil Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 21. Brazil Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 22. Argentina Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 23. Argentina Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 24. Argentina Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 25. Rest of South America Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 26. Rest of South America Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 27. Rest of South America Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 28. Asia Pacific Transdermal Skin Patches, by Country USD Million (2014-2019)
  • Table 29. Asia Pacific Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 30. Asia Pacific Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 31. Asia Pacific Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 32. China Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 33. China Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 34. China Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 35. Japan Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 36. Japan Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 37. Japan Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 38. India Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 39. India Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 40. India Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 41. South Korea Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 42. South Korea Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 43. South Korea Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 44. Taiwan Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 45. Taiwan Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 46. Taiwan Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 47. Australia Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 48. Australia Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 49. Australia Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 50. Rest of Asia-Pacific Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 51. Rest of Asia-Pacific Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 52. Rest of Asia-Pacific Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 53. Europe Transdermal Skin Patches, by Country USD Million (2014-2019)
  • Table 54. Europe Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 55. Europe Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 56. Europe Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 57. Germany Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 58. Germany Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 59. Germany Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 60. France Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 61. France Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 62. France Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 63. Italy Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 64. Italy Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 65. Italy Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 66. United Kingdom Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 67. United Kingdom Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 68. United Kingdom Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 69. Netherlands Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 70. Netherlands Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 71. Netherlands Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 72. Rest of Europe Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 73. Rest of Europe Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 74. Rest of Europe Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 75. MEA Transdermal Skin Patches, by Country USD Million (2014-2019)
  • Table 76. MEA Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 77. MEA Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 78. MEA Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 79. Middle East Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 80. Middle East Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 81. Middle East Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 82. Africa Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 83. Africa Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 84. Africa Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 85. North America Transdermal Skin Patches, by Country USD Million (2014-2019)
  • Table 86. North America Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 87. North America Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 88. North America Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 89. United States Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 90. United States Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 91. United States Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 92. Canada Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 93. Canada Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 94. Canada Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 95. Mexico Transdermal Skin Patches, by Type USD Million (2014-2019)
  • Table 96. Mexico Transdermal Skin Patches, by Application USD Million (2014-2019)
  • Table 97. Mexico Transdermal Skin Patches, by End Use USD Million (2014-2019)
  • Table 98. Transdermal Skin Patches Sales: by Type(k Units)
  • Table 99. Transdermal Skin Patches Sales Drug in Adhesive , by Region k Units (2014-2019)
  • Table 100. Transdermal Skin Patches Sales Matrix , by Region k Units (2014-2019)
  • Table 101. Transdermal Skin Patches Sales Reservoir , by Region k Units (2014-2019)
  • Table 102. Transdermal Skin Patches Sales Vapor , by Region k Units (2014-2019)
  • Table 103. Transdermal Skin Patches Sales Other , by Region k Units (2014-2019)
  • Table 104. Transdermal Skin Patches Sales: by Application(k Units)
  • Table 105. Transdermal Skin Patches Sales Hospital Pharmacies , by Region k Units (2014-2019)
  • Table 106. Transdermal Skin Patches Sales Retail Pharmacies , by Region k Units (2014-2019)
  • Table 107. Transdermal Skin Patches Sales Online Pharmacies , by Region k Units (2014-2019)
  • Table 108. Transdermal Skin Patches Sales: by End Use(k Units)
  • Table 109. Transdermal Skin Patches Sales Hospital Pharmacies , by Region k Units (2014-2019)
  • Table 110. Transdermal Skin Patches Sales Online Pharmacies , by Region k Units (2014-2019)
  • Table 111. Transdermal Skin Patches Sales Independent Pharmacies & Drug Stores , by Region k Units (2014-2019)
  • Table 112. South America Transdermal Skin Patches Sales, by Country k Units (2014-2019)
  • Table 113. South America Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 114. South America Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 115. South America Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 116. Brazil Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 117. Brazil Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 118. Brazil Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 119. Argentina Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 120. Argentina Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 121. Argentina Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 122. Rest of South America Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 123. Rest of South America Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 124. Rest of South America Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 125. Asia Pacific Transdermal Skin Patches Sales, by Country k Units (2014-2019)
  • Table 126. Asia Pacific Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 127. Asia Pacific Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 128. Asia Pacific Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 129. China Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 130. China Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 131. China Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 132. Japan Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 133. Japan Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 134. Japan Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 135. India Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 136. India Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 137. India Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 138. South Korea Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 139. South Korea Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 140. South Korea Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 141. Taiwan Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 142. Taiwan Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 143. Taiwan Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 144. Australia Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 145. Australia Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 146. Australia Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 147. Rest of Asia-Pacific Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 148. Rest of Asia-Pacific Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 149. Rest of Asia-Pacific Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 150. Europe Transdermal Skin Patches Sales, by Country k Units (2014-2019)
  • Table 151. Europe Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 152. Europe Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 153. Europe Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 154. Germany Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 155. Germany Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 156. Germany Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 157. France Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 158. France Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 159. France Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 160. Italy Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 161. Italy Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 162. Italy Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 163. United Kingdom Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 164. United Kingdom Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 165. United Kingdom Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 166. Netherlands Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 167. Netherlands Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 168. Netherlands Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 169. Rest of Europe Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 170. Rest of Europe Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 171. Rest of Europe Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 172. MEA Transdermal Skin Patches Sales, by Country k Units (2014-2019)
  • Table 173. MEA Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 174. MEA Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 175. MEA Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 176. Middle East Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 177. Middle East Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 178. Middle East Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 179. Africa Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 180. Africa Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 181. Africa Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 182. North America Transdermal Skin Patches Sales, by Country k Units (2014-2019)
  • Table 183. North America Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 184. North America Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 185. North America Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 186. United States Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 187. United States Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 188. United States Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 189. Canada Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 190. Canada Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 191. Canada Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 192. Mexico Transdermal Skin Patches Sales, by Type k Units (2014-2019)
  • Table 193. Mexico Transdermal Skin Patches Sales, by Application k Units (2014-2019)
  • Table 194. Mexico Transdermal Skin Patches Sales, by End Use k Units (2014-2019)
  • Table 195. Transdermal Skin Patches: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Transdermal Skin Patches: by Type(USD Million)
  • Table 205. Transdermal Skin Patches Drug in Adhesive , by Region USD Million (2020-2025)
  • Table 206. Transdermal Skin Patches Matrix , by Region USD Million (2020-2025)
  • Table 207. Transdermal Skin Patches Reservoir , by Region USD Million (2020-2025)
  • Table 208. Transdermal Skin Patches Vapor , by Region USD Million (2020-2025)
  • Table 209. Transdermal Skin Patches Other , by Region USD Million (2020-2025)
  • Table 210. Transdermal Skin Patches: by Application(USD Million)
  • Table 211. Transdermal Skin Patches Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 212. Transdermal Skin Patches Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 213. Transdermal Skin Patches Online Pharmacies , by Region USD Million (2020-2025)
  • Table 214. Transdermal Skin Patches: by End Use(USD Million)
  • Table 215. Transdermal Skin Patches Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 216. Transdermal Skin Patches Online Pharmacies , by Region USD Million (2020-2025)
  • Table 217. Transdermal Skin Patches Independent Pharmacies & Drug Stores , by Region USD Million (2020-2025)
  • Table 218. South America Transdermal Skin Patches, by Country USD Million (2020-2025)
  • Table 219. South America Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 220. South America Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 221. South America Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 222. Brazil Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 223. Brazil Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 224. Brazil Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 225. Argentina Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 226. Argentina Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 227. Argentina Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 228. Rest of South America Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 229. Rest of South America Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 230. Rest of South America Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 231. Asia Pacific Transdermal Skin Patches, by Country USD Million (2020-2025)
  • Table 232. Asia Pacific Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 233. Asia Pacific Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 234. Asia Pacific Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 235. China Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 236. China Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 237. China Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 238. Japan Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 239. Japan Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 240. Japan Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 241. India Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 242. India Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 243. India Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 244. South Korea Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 245. South Korea Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 246. South Korea Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 247. Taiwan Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 248. Taiwan Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 249. Taiwan Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 250. Australia Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 251. Australia Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 252. Australia Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 253. Rest of Asia-Pacific Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 254. Rest of Asia-Pacific Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 255. Rest of Asia-Pacific Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 256. Europe Transdermal Skin Patches, by Country USD Million (2020-2025)
  • Table 257. Europe Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 258. Europe Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 259. Europe Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 260. Germany Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 261. Germany Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 262. Germany Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 263. France Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 264. France Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 265. France Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 266. Italy Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 267. Italy Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 268. Italy Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 269. United Kingdom Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 270. United Kingdom Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 271. United Kingdom Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 272. Netherlands Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 273. Netherlands Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 274. Netherlands Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 275. Rest of Europe Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 276. Rest of Europe Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 277. Rest of Europe Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 278. MEA Transdermal Skin Patches, by Country USD Million (2020-2025)
  • Table 279. MEA Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 280. MEA Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 281. MEA Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 282. Middle East Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 283. Middle East Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 284. Middle East Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 285. Africa Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 286. Africa Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 287. Africa Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 288. North America Transdermal Skin Patches, by Country USD Million (2020-2025)
  • Table 289. North America Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 290. North America Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 291. North America Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 292. United States Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 293. United States Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 294. United States Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 295. Canada Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 296. Canada Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 297. Canada Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 298. Mexico Transdermal Skin Patches, by Type USD Million (2020-2025)
  • Table 299. Mexico Transdermal Skin Patches, by Application USD Million (2020-2025)
  • Table 300. Mexico Transdermal Skin Patches, by End Use USD Million (2020-2025)
  • Table 301. Transdermal Skin Patches Sales: by Type(k Units)
  • Table 302. Transdermal Skin Patches Sales Drug in Adhesive , by Region k Units (2020-2025)
  • Table 303. Transdermal Skin Patches Sales Matrix , by Region k Units (2020-2025)
  • Table 304. Transdermal Skin Patches Sales Reservoir , by Region k Units (2020-2025)
  • Table 305. Transdermal Skin Patches Sales Vapor , by Region k Units (2020-2025)
  • Table 306. Transdermal Skin Patches Sales Other , by Region k Units (2020-2025)
  • Table 307. Transdermal Skin Patches Sales: by Application(k Units)
  • Table 308. Transdermal Skin Patches Sales Hospital Pharmacies , by Region k Units (2020-2025)
  • Table 309. Transdermal Skin Patches Sales Retail Pharmacies , by Region k Units (2020-2025)
  • Table 310. Transdermal Skin Patches Sales Online Pharmacies , by Region k Units (2020-2025)
  • Table 311. Transdermal Skin Patches Sales: by End Use(k Units)
  • Table 312. Transdermal Skin Patches Sales Hospital Pharmacies , by Region k Units (2020-2025)
  • Table 313. Transdermal Skin Patches Sales Online Pharmacies , by Region k Units (2020-2025)
  • Table 314. Transdermal Skin Patches Sales Independent Pharmacies & Drug Stores , by Region k Units (2020-2025)
  • Table 315. South America Transdermal Skin Patches Sales, by Country k Units (2020-2025)
  • Table 316. South America Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 317. South America Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 318. South America Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 319. Brazil Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 320. Brazil Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 321. Brazil Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 322. Argentina Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 323. Argentina Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 324. Argentina Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 325. Rest of South America Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 326. Rest of South America Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 327. Rest of South America Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 328. Asia Pacific Transdermal Skin Patches Sales, by Country k Units (2020-2025)
  • Table 329. Asia Pacific Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 330. Asia Pacific Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 331. Asia Pacific Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 332. China Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 333. China Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 334. China Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 335. Japan Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 336. Japan Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 337. Japan Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 338. India Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 339. India Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 340. India Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 341. South Korea Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 342. South Korea Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 343. South Korea Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 344. Taiwan Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 345. Taiwan Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 346. Taiwan Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 347. Australia Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 348. Australia Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 349. Australia Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 350. Rest of Asia-Pacific Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 351. Rest of Asia-Pacific Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 352. Rest of Asia-Pacific Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 353. Europe Transdermal Skin Patches Sales, by Country k Units (2020-2025)
  • Table 354. Europe Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 355. Europe Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 356. Europe Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 357. Germany Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 358. Germany Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 359. Germany Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 360. France Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 361. France Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 362. France Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 363. Italy Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 364. Italy Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 365. Italy Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 366. United Kingdom Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 367. United Kingdom Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 368. United Kingdom Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 369. Netherlands Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 370. Netherlands Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 371. Netherlands Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 372. Rest of Europe Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 373. Rest of Europe Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 374. Rest of Europe Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 375. MEA Transdermal Skin Patches Sales, by Country k Units (2020-2025)
  • Table 376. MEA Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 377. MEA Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 378. MEA Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 379. Middle East Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 380. Middle East Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 381. Middle East Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 382. Africa Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 383. Africa Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 384. Africa Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 385. North America Transdermal Skin Patches Sales, by Country k Units (2020-2025)
  • Table 386. North America Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 387. North America Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 388. North America Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 389. United States Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 390. United States Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 391. United States Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 392. Canada Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 393. Canada Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 394. Canada Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 395. Mexico Transdermal Skin Patches Sales, by Type k Units (2020-2025)
  • Table 396. Mexico Transdermal Skin Patches Sales, by Application k Units (2020-2025)
  • Table 397. Mexico Transdermal Skin Patches Sales, by End Use k Units (2020-2025)
  • Table 398. Transdermal Skin Patches: by Type(USD/Units)
  • Table 399. Research Programs/Design for This Report
  • Table 400. Key Data Information from Secondary Sources
  • Table 401. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transdermal Skin Patches: by Type USD Million (2014-2019)
  • Figure 5. Global Transdermal Skin Patches: by Application USD Million (2014-2019)
  • Figure 6. Global Transdermal Skin Patches: by End Use USD Million (2014-2019)
  • Figure 7. South America Transdermal Skin Patches Share (%), by Country
  • Figure 8. Asia Pacific Transdermal Skin Patches Share (%), by Country
  • Figure 9. Europe Transdermal Skin Patches Share (%), by Country
  • Figure 10. MEA Transdermal Skin Patches Share (%), by Country
  • Figure 11. North America Transdermal Skin Patches Share (%), by Country
  • Figure 12. Global Transdermal Skin Patches: by Type k Units (2014-2019)
  • Figure 13. Global Transdermal Skin Patches: by Application k Units (2014-2019)
  • Figure 14. Global Transdermal Skin Patches: by End Use k Units (2014-2019)
  • Figure 15. South America Transdermal Skin Patches Share (%), by Country
  • Figure 16. Asia Pacific Transdermal Skin Patches Share (%), by Country
  • Figure 17. Europe Transdermal Skin Patches Share (%), by Country
  • Figure 18. MEA Transdermal Skin Patches Share (%), by Country
  • Figure 19. North America Transdermal Skin Patches Share (%), by Country
  • Figure 20. Global Transdermal Skin Patches: by Type USD/Units (2014-2019)
  • Figure 21. Global Transdermal Skin Patches share by Players 2019 (%)
  • Figure 22. Global Transdermal Skin Patches share by Players (Top 3) 2019(%)
  • Figure 23. Global Transdermal Skin Patches share by Players (Top 5) 2019(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 26. Johnson & Johnson (United States) Revenue: by Geography 2019
  • Figure 27. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis AG (Switzerland) Revenue: by Geography 2019
  • Figure 29. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Mylan N.V. (United States) Revenue: by Geography 2019
  • Figure 31. Teva Pharmaceutical Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Teva Pharmaceutical Industries (Israel) Revenue: by Geography 2019
  • Figure 33. Luye Pharma Group (China) Revenue, Net Income and Gross profit
  • Figure 34. Luye Pharma Group (China) Revenue: by Geography 2019
  • Figure 35. Hisamitsu Pharmaceutical (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Hisamitsu Pharmaceutical (Japan) Revenue: by Geography 2019
  • Figure 37. Mundipharma International (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Mundipharma International (United Kingdom) Revenue: by Geography 2019
  • Figure 39. Purdue Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 40. Purdue Pharma (United States) Revenue: by Geography 2019
  • Figure 41. Global Transdermal Skin Patches: by Type USD Million (2020-2025)
  • Figure 42. Global Transdermal Skin Patches: by Application USD Million (2020-2025)
  • Figure 43. Global Transdermal Skin Patches: by End Use USD Million (2020-2025)
  • Figure 44. South America Transdermal Skin Patches Share (%), by Country
  • Figure 45. Asia Pacific Transdermal Skin Patches Share (%), by Country
  • Figure 46. Europe Transdermal Skin Patches Share (%), by Country
  • Figure 47. MEA Transdermal Skin Patches Share (%), by Country
  • Figure 48. North America Transdermal Skin Patches Share (%), by Country
  • Figure 49. Global Transdermal Skin Patches: by Type k Units (2020-2025)
  • Figure 50. Global Transdermal Skin Patches: by Application k Units (2020-2025)
  • Figure 51. Global Transdermal Skin Patches: by End Use k Units (2020-2025)
  • Figure 52. South America Transdermal Skin Patches Share (%), by Country
  • Figure 53. Asia Pacific Transdermal Skin Patches Share (%), by Country
  • Figure 54. Europe Transdermal Skin Patches Share (%), by Country
  • Figure 55. MEA Transdermal Skin Patches Share (%), by Country
  • Figure 56. North America Transdermal Skin Patches Share (%), by Country
  • Figure 57. Global Transdermal Skin Patches: by Type USD/Units (2020-2025)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Novartis AG (Switzerland)
  • Mylan N.V. (United States)
  • Teva Pharmaceutical Industries (Israel)
  • Luye Pharma Group (China)
  • Hisamitsu Pharmaceutical (Japan)
  • Mundipharma International (United Kingdom)
  • Purdue Pharma (United States)
Additional players considered in the study are as follows:
Purdue Pharma L.P. (United States) , Endo International plc (Ireland) , Boehringer Ingelheim (Germany)
Select User Access Type

Key Highlights of Report


Jun 2020 244 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Transdermal Skin Patches Quantitative research analysis
Global Transdermal Skin Patches Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Transdermal Skin Patches Report?

Have a Query? Click Here

Other Related Reports

Kidney Cancer Drugs Comprehensive Study by Type (Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib), Torisel (Temsirolimus)...
$ 3650
Obesity Treatment Comprehensive Study by Application (Children, Adults), Drugs (Combination Drugs, Appetite Suppressants, Malabsorption, Satiety), Treatment (Medication, Surgery, Lifestyle Changes), ...
$ 3750
Plant Sterol Esters Comprehensive Study by Type (Oil, Powder), End Users (Food & Beverages, Dairy Products, Pharmaceutical, Cosmetics) Players and Region - Global Market Outlook to 2026
$ 3500
Companion Diagnostics Comprehensive Study by End-users (Pharma Companies, Reference Laboratories, CRO, Others), Product & Service (Assay kits & Reagents, Software & Services), Technology Type (Polyme...
$ 3750
Vaccines & Vaccination Comprehensive Study by Type (Monovalent Vaccines, Multivalent Vaccines), Application (Pediatrics disease, Adults disease), Route of Administration (Intramuscular and Subcutaneo...
$ 3750
Dog Calcium Supplement Comprehensive Study by Application (Households, Veterinary Hospitals, Pet Cannels, Other), Form (Powder, Paste, Liquid, Capsules, Other), Distribution Channel (Online, Offline)...
$ 3800